MarketInOut Stock Screener Log In | Sign Up

Bafna Pharmaceuticals Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:32
Bafna Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization10,642 mln
Float3.54 mln

EPS

3.29
Stretched

P / E

137
Highly speculative

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.77
Likely reliable

Relative Strength

88 / 100
Strongly outperforming

Debt / Equity

0.39
Low leverage

Business Description

Founded in 1981 and headquartered in Chennai, India, Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP that produces and distributes a range of ready-to-use medicine products. Beyond serving the domestic Indian market, the company reaches customers across a wide range of international markets, including Europe, the United Kingdom, Australia, Sri Lanka, Africa, the Philippines, Tanzania, Nigeria, and various Commonwealth nations.

Key Fundamentals

EPS3.29
P/E137
ROE8.58
RPS59.40
ROIC4.00
ROA4.77
Interest Cover1.43
EBITDA, mln178
EV / EBITDA51.11
EV / EBIT80.31
Revenue, mln1,426
EV / Revenue6.39

Quote Details

Last 449.70
Change 8.8 (2%)
Open 449.70
Volume 12,235
Turnover 5,502,080
Average Volume 9,779.76

Financial Ratios

Pre-Tax Profit Margin5
Current Ratio1.57
Price / Book9.29
Price / Tangible Book9.29
Price / Cash Flow119
Debt / Equity0.39
Price / Sales6.26
PEG Ratio13.04

Financial Strength

Altman Z-Score7.61
Piotroski F-Score 6 / 9
Beneish M-Score-2.77
Price to Graham Number5.77

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.9% 33 / 100   
1 Month 28.85% 98 / 100   
2 Months 96.38% 99 / 100   
6 Months 239% 100 / 100   
1 Year 227% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog